The present case was accurately selected for this aggressive protocol (no comorbidities and good local control of the disease). HITHOC was well tolerated during surgery and no major complication neither toxicities occurred. Compared to cisplatin, the mitomycin-C plasmatic concentration is very lower (as reported in a pharmacokinetic study7), thus reducing the risk of adverse effect related to the drug in the post-op.